Crohn´s Disease Clinical Trial
Official title:
Soft Ostheopathic Techniques Improve the Quality of Life in Patients With Crohn's Disease. A Randomized Controlled Trial.
Crohn's disease (CD) is an inflammatory bowel disease with a high prevalence. Its etiology is unknown and is considered a multifactorial disease. It is known that the existence of a genetic factor, industrialization and development of the country and environmental factors have great influence on the appearance of intestinal pathology (the Val; Buderus; Molodecky). CD is a chronic inflammatory bowel disease localized throughout the course of the digestive tract (oral-anal). The aim of this study is to evaluate the effect of a treatment program combining technical nonmanipulative appropriate in affected patients (CD) to increase the overall quality of life and related EC, lower abdominal pain direct and indirect osteopathic soft, observe the sense of change after treatment, and psychological aspects.
All of the participants were recruited, in a non-probabilistic way, from the Valencian
Association of Enfermos de Crohn y Colitis Ulcerosa (ACCU) The participants were allocated
to two different groups depending on their possibility of participation in the therapeutic
sessions. The group that received the therapy was called experimental group (EG) and the
group, who did not, control group (CG). The participants were allocated independently of
their disease status (outbreak or remission).
An experimental study carried out during a period of four weeks in order to explore the
effect of the specific treatment on the following outcomes: global quality of life, quality
of life in CD and pain.
The participants, in the EG were treated in three sessions, that lasted 45 minutes, during
the study duration (1 session each 9-10 days). The physiotherapist who applied the treatment
had an extensive experience in manual therapy.
Both groups come to laboratory two times for the assessment, one at the beginning of the
study and the other one at the end. In each session several questionnaires were administered
by a physiotherapist who was blinded to the group assignment.
;
Allocation: Non-Randomized, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01860651 -
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
|
N/A | |
| Completed |
NCT01102855 -
Endomicroscopy and Crohn´s Disease
|
N/A | |
| Completed |
NCT01279577 -
Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease
|
Phase 2 | |
| Completed |
NCT01086553 -
9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease
|
Phase 3 | |
| Completed |
NCT01289366 -
Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)
|
N/A | |
| Recruiting |
NCT06006039 -
The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.
|
||
| Recruiting |
NCT04022083 -
Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease
|
||
| Completed |
NCT03890445 -
Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease
|
||
| Completed |
NCT01564823 -
Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease
|
Phase 3 | |
| Completed |
NCT01768858 -
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
|
||
| Completed |
NCT01417702 -
Endoscopy for Assessment of Mucosal Healing in IBD
|
||
| Completed |
NCT01417715 -
Endomicroscopy for Assessment of Mucosal Healing
|
||
| Terminated |
NCT00862121 -
A Study With Pentasa in Patients With Active Crohn's Disease
|
Phase 3 |